Altor invests in IMBOX in partnership with the founder René Marker and the Grundtvig family

Altor Fund VI (“Altor”) has signed an agreement to acquire a majority stake in IMBOX Protection A/S (“IMBOX”) and enter into a partnership with the founder, René Marker, and the Grundtvig family. Altor will support the founder and the company on its continued international growth journey. The founder and the Grundtvig family will remain significant shareholders and continue supporting the development of IMBOX. René Marker will continue in his role as CEO.

Founded by René Marker in 2009 in Denmark, IMBOX is a niche engineering company and a first mover in providing automated footwear protection machines through an equipment-as-a- service model to a wide range of retail customers across both physical stores and e-commerce channels. The company is headquartered in Skødstrup, Denmark where it designs and develops the globally patented technology. IMBOX is currently present in 37 countries and has an installed base of ~9,700 machines in ~8,900 stores. Across its installed base, IMBOX sells one treatment per second, and generates around DKK 1 billion of revenue for retailers.

“We are really excited to hit the ground running with Altor as a partner. We will benefit from their long expertise of helping companies scale internationally and add relevant experience for the next phase of our joint growth journey. Together, we will ensure that more end-users and stores will have access to our offering” says René Marker, Founder and CEO of IMBOX.

Henrik Grundtvig from the Grundtvig family continued, “Early on, we had the opportunity to help bring a Danish innovation to life. Since then, we have built a competitive o`ering with globally patented technologies. We are excited to continue the partnership with René and Altor while still only seeing the beginning of the IMBOX journey”.

“IMBOX is an excellent example of a strong and proven technology built to meet the needs of its industry and customers. We are really impressed by what René and the Grundtvig family have built over the years and look forward to being part of continued growth journey.” says Jens Browaldh, Partner at Altor. “As IMBOX embarks on its next chapter, the company will continue to benefit from René’s leadership and his team’s deep technical and industry expertise, now complemented by Altor’s experience to support accelerated growth. Our ambition is to at least triple the installed base over the next 3 to 5 years,” says Karl Svenningson, Principal at Altor.

Parties have agreed not to disclose the financial details.

About Altor

Since inception, the family of Altor funds has raised more than EUR 12 billion in total commitments. The funds have invested in more than 100 companies. The investments have been made in medium-sized companies predominantly in Nordic and DACH with the aim to create value through growth initiatives and operational improvements. Among current and past investments are Eleda, FLSmidth, Toteme, Silo AI, Marshall and Helly Hansen.

About Imbox

IMBOX develops easy-to-use premium machines for automated footwear protection at the point-of-sale. The product portfolio currently includes two machines; the IMBOX Original and IMBOX Flagship, which has won a Red Dot Design Award. The solution is provided through a hardware-as-a-service revenue-sharing model to omnichannel footwear and sports retailers, department stores and e-commerce shops. IMBOX is headquartered in Skødstrup, Denmark.

Press contact

Karin Åström

Head of Communications

karin.astrom@altor.com

+46 707 64 86 59

Categories: News

Tags:

CapMan Real Estate invests SEK 692 million in 205-unit multifamily housing development in Stockholm

Capman

CapMan Real Estate, through its third value-add fund CapMan Nordic Real Estate III (“CMNRE III”, the “Fund”), has acquired a residential development project comprising 205 rental units in Jakobsberg, Järfälla from JM. The project is expected to be completed in Q4 2027.

Located in a highly attractive micro-location with excellent access to public transportation, the site offers commuting time of under 25 minutes to central Stockholm. The area benefits from strong tenant demand and a limited supply of rental housing. Designed to meet high sustainability standards, the project will feature BREEAM certification, a minimum EPC rating of B, solar panels, EV charging stations, and aims for EU Taxonomy alignment. Tenants will benefit from a range of mobility solutions, including access to carpool, to support sustainable commuting.

“We are pleased to grow our residential portfolio in Greater Stockholm and act on compelling opportunities in the current market. With strong fundamentals and structural supply-demand imbalances, the residential sector remains a high-conviction theme for us. This project is designed to meet the growing need for high-quality, middle-income rental housing in one of Europe’s fastest-growing metropolitan areas,” says Pontus Danielsson, Investment Manager at CapMan Real Estate.

“This acquisition is fully aligned with our strategy of investing in sustainable, well-located residential assets across key Nordic growth regions. With strong local market knowledge and a robust deal pipeline, we are well positioned to continue scaling our residential platform,” adds Marcus Lotzman, Head of Transactions, Sweden at CapMan Real Estate.

The transaction is structured as a forward purchase, with closing expected upon project completion in Q4 2027. It marks the 22nd investment made by CMNRE III.

CapMan Real Estate manages approximately €5.5 billion in real estate assets, with a team of over 80 professionals based in Helsinki, Stockholm, Copenhagen, Oslo and London.

For further information, please contact:

Marcus Lotzman, Head of Transactions, Sweden, +46 70 680 60 81

Pontus Danielsson, Investment Manager, +46 70 385 58 00

About CapMan

CapMan is a leading Nordic private asset expert with an active approach to value creation and 6.4 billion in assets under management. As one of the private equity pioneers in the Nordics we have developed hundreds of companies and assets creating significant value for over three decades. Our objective is to provide attractive returns and innovative solutions to investors by enabling change across our portfolio companies. An example of this is greenhouse gas reduction targets that we have set under the Science Based Targets initiative in line with the 1.5°C scenario and our commitment to net-zero GHG emissions by 2040. We have a broad presence in the unlisted market through our local and specialised teams. Our investment strategies cover real estate and infrastructure assets, natural capital and minority and majority investments in portfolio companies. We also provide wealth management solutions. Altogether, CapMan employs around 200 professionals in Helsinki, Jyväskylä, Stockholm, Copenhagen, Oslo, London and Luxembourg. We are listed on Nasdaq Helsinki since 2001. www.capman.com

Categories: News

Tags:

Ardian finalizes the sale of its iconic Parisian Renaissance building, located in the heart of the Golden Triangle

Ardian

Ardian, a world-leading private investment firm, announces the sale of the Renaissance building, one of its iconic real estate assets, located at 26bis – 32 rue François 1er, in the Paris Golden Triangle.

Ardian had acquired this historic complex, the former headquarters of the Europe 1 radio station, in May 2018 through Ardian Real Estate European Fund I. Ardian led a major restructuring project to reposition it as a unique, modern, and exceptional mixed-use building (for both office and retail), meeting the highest market standards.

Today, Renaissance is home to international law firm A&O Shearman, which occupies high-end office space, as well as prestigious names such as world-renowned art gallery Hauser & Wirth, Japanese fashion house Issey Miyake and luxury car manufacturer Jaguar Land Rover.

“Renaissance embodies a unique product which is the fruit of a project management effort of rare complexity and exemplary execution. The inimitability of this project, both in terms of its location and the quality of its execution, makes it a benchmark in the market. It is precisely this uniqueness that gives Renaissance its remarkable liquidity, even in a core market environment where there are not currently many transactions of this scale.” Sébastien Bégué, Head of Real Estate Investment Management & Managing Director, Ardian

“The sale of Renaissance, in a European market now showing signs of recovery, is a perfect illustration of Ardian’s ability to anticipate investor expectations and enhance the value of exceptional assets. This success testifies to the unique expertise of our teams in repositioning emblematic buildings and confirms the renewed appetite of long-term investors for high-quality products.” Stéphanie Bensimon, Member of the Executive Committee, Member of the Board of Ardian France & Head of Real Estate, Ardian

ABOUT ARDIAN

Ardian is a world-leading private investment firm, managing or advising $180bn of assets on behalf of more than 1,850 clients globally. Our broad expertise, spanning Private Equity, Real Assets and Credit, enables us to offer a wide range of investment opportunities and respond flexibly to our clients’ differing needs. Through Ardian Customized Solutions we create bespoke portfolios that allow institutional clients to specify the precise mix of assets they require and to gain access to funds managed by leading third-party sponsors. Private Wealth Solutions offers dedicated services and access solutions for private banks, family offices and private institutional investors worldwide. Ardian’s main shareholding group is its employees and we place great emphasis on developing its people and fostering a collaborative culture based on collective intelligence. Our 1,050+ employees, spread across 19 offices in Europe, the Americas, Asia and Middle East are strongly committed to the principles of Responsible Investment and are determined to make finance a force for good in society. Our goal is to deliver excellent investment performance combined with high ethical standards and social responsibility.
At Ardian we invest all of ourselves in building companies that last.

Media Contacts

Ardian

Categories: News

Tags:

VIVEbiotech Appoints Patricio Massera as President

Ampersand

Veteran CDMO executive to guide next phase of global expansion and operational excellence for lentiviral vector manufacturer.

San Sebastián, Gipuzkoa, Spain – July 3, 2025 – VIVEbiotech, a leading Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral vector (LVV) development and manufacturing for in vivo and ex vivo gene and cell therapies, today announced the appointment of Patricio Massera as President, in addition to his role on the VIVEbiotech Board of Directors.

The appointment marks a significant step in VIVEbiotech’s strategy to scale its capabilities, expand globally, and enhance operational quality and excellence following a recent growth investment from Ampersand Capital Partners, a life sciences and healthcare-focused private equity firm.

Mr. Massera has over 25 years of leadership experience in the biopharmaceutical CDMO sector. Most recently, he served as CEO of AGC Biologics, where he led the company through global facility expansions and advanced its reputation for quality, innovation, and customer satisfaction. In his prior executive roles, Patricio focused on scaling operations, driving quality and operational excellence, and building world-class teams.

“I am honored to join VIVEbiotech at such a pivotal point in its evolution. I firmly believe that VIVE’s unique value proposition is redefining the standards by which CDMOs address customer needs and drive meaningful advancements that improve lives.” said Mr. Massera. “I look forward to working closely with the Board and the leadership team to enhance operational robustness, expand capabilities, and strengthen the strategic partnerships that define VIVE’s commitment to customer success.”

Mr. Massera joins VIVEbiotech’s leadership team alongside Chairperson Dr. Stefan Beyer—a seasoned CDMO executive and former CEO of Vibalogics—and CEO Jon Alberdi, who has led the company’s emergence as a global leader in lentiviral vector manufacturing.

“Patricio brings a unique combination of strategic vision, technical expertise, and operational excellence,” said Dr. Stefan Beyer, Chairperson of VIVEbiotech. “He has consistently demonstrated a strong ability to scale organizations while upholding excellence in quality and customer service. The Board is confident in his ability to help lead VIVEbiotech into its next phase of growth. We are delighted to welcome him and look forward to working closely together.”

Jon Alberdi, CEO, VIVEbiotech added, “Patricio’s deep industry knowledge and leadership skills are a perfect fit for our ambitious goals. I look forward to working together to deliver exceptional value to our clients and to further strengthen our position as a leading CDMO.”

VIVEbiotech is one of the few CDMOs globally with deep expertise in both ex vivo and in vivo lentiviral vector development and manufacturing. Its fully integrated service offering supports therapies across a range of indications including oncology (CAR-T, NK), autoimmune diseases, and vaccines. VIVE serves established global pharmaceutical leaders as well as emerging, innovative start-ups, with a customer base spanning Europe, the U.S., and Australia.

About VIVEbiotech

VIVEbiotech is a Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral vectors for gene and cell therapy. Founded in 2015, VIVEbiotech operates under EMA and FDA standards, serving over 40 biotech companies globally. The company focuses on scalable, high-yield manufacturing processes and cutting-edge technologies. With expertise in both ex vivo and in vivo applications, VIVEbiotech supports the development and commercialization of therapies for cancers and rare diseases. For more information about VIVEbiotech, please visit vivebiotech.com.

About Ampersand Capital Partners

Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors. For additional information, visit AmpersandCapital.com or follow us on LinkedIn.

Categories: People

Adelis exits its investment in Europa Biosite

Adelis Equity
Report this content

Adelis Equity Partners Fund II (“Adelis”) has divested its majority stake in Europa Biosite, a specialist distributor of Life Science research reagents to EQT Healthcare Growth

Following the acquisition by Adelis in 2021, Europa Biosite has executed on a successful international buy and build strategy acquiring 5 companies in 4 years. By doing so the Company has established a position as the leading specialist distributor in its field – offering innovative products to thousands of Life Science researchers across the continent. In parallel, significant investments have been made into digital tools and marketing that enable a differentiated supplier value proposition and fuel new supplier acquisition and organic growth.

“We are very proud of the part we have played in building a unique European business that supports life science researchers in reaching their goals – ultimately helping to understand and cure disease. On behalf of Adelis, we would like to thank management and all employees, as well as our minority partners and board colleagues for their strong efforts these past years” say Lene Stern and Rasmus Molander. Sune Schmølker, CEO of Europa Biosite says: “We are uniquely positioned to take part in the continued growth of the Life Science reagent market after the significant investments made into building the Group. I am very grateful for the support we have received from Adelis and the board of directors over these past years. I am looking forward to working with the new owners to continue the development of our business”.

The parties have agreed not to disclose the purchase price. The transaction is subject to customary clearance from competition authorities.

Adelis was advised by Houlihan Lokey and White & Case on the transaction.

For further information:

Lucia Morris, Adelis Equity Partners, +46 76 103 12 92, lucia.morris@adelisequity.com

Sune Schmølker, Europa Biosite, sune.schmolker@europabiosite.com

About Europa Biosite

Europa Biosite is a specialist distributor of Life Science research reagents. Carrying a portfolio of over 10 million SKUs, it supports thousands of researchers across Europe and North America in reaching their research objectives. The company has 180 employees covering 17 countries, the majority of whom are scientifically trained and therefore able to provide expert technical support to customers. Under Adelis’ ownership the company has completed 5 acquisitions – creating a truly pan-European commercial footprint and adding further innovative products to the portfolio. For further information, please visit www.europabiosite.com.

About Adelis Equity Partners

Adelis is a growth partner for well-positioned companies in the Nordics and DACH region. Adelis partners with management and/or owners to build businesses in growth segments and with strong market positions. Since raising its first fund in 2013, Adelis has been one of the most active investors in the Nordic middle-market, making 47 platform investments and more than 270 add-on acquisitions. Adelis today manages approximately €4.5 billion in capital. For more information, please visit www.adelisequity.com.

Categories: News

EQT to acquire Europa Biosite, a distributor of life science products

eqt

Europa Biosite

  • EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across Europe and North America, from Adelis Equity
  • EQT will support Europa Biosite’s next phase of growth through commercial excellence initiatives, digital upgrades, expanded product access, and continued M&A, with the company set to benefit from continued demand for advanced research tools
  • The investment builds on EQT’s track record in specialised distribution, including Azelis, Beijer Ref, and OEM International

EQT Healthcare Growth (“EQT”) has agreed to acquire a majority stake in Europa Biosite (or “the Company”) – a distributor of high-quality research-use-only (RUO) life science reagents, chemicals, and biological substances used in healthcare R&D – from Adelis Equity. Headquartered in Stockholm, the Company operates in 17 countries across Europe and North America and supports more than 60,000 researchers in academia and biopharma.

Europa Biosite offers access to over ten million individual scientific products essential to life sciences research, such as antibodies, biochemicals, diagnostic kits, and ethically sourced biospecimens, from a wide range of science-led suppliers. It has grown to become a partner for both suppliers and scientists, building on its highly localized footprint and strong technical sales capabilities. The Company serves a fragmented and fast-moving industry, which is expected to benefit from stable research funding.

EQT Healthcare Growth seeks to scale healthcare companies by building commercial muscle and expanding reach, building on EQT’s three-decade track record in the healthcare sector. Europa Biosite will draw on this experience to expand its own-brand offering in biospecimens, continue its acquisition strategy to strengthen local market presence and expand to new geographies, and invest in new digital infrastructure. The Company is also set to benefit from EQT’s track record in specialized distribution, including Azelis, Beijer Ref, and OEM International, as well as EQT’s industrial advisor network, with senior EQT advisor Kate Swann set to lead Europa Biosite’s Board.

Rikke Kjær Nielsen, Partner in the EQT Healthcare Growth advisory team, commented: ”Europa Biosite supports European scientific research by connecting thousands of labs with the reagents they need to advance discovery. With our support, the company will be set up to scale its business through investments into digital tools, strengthening of its supplier network, and acceleration of its M&A platform. We are proud to support a company that enables critical research and look forward to partnering with Europa Biosite’s management team on the next leg of their journey.”

“We’re excited to partner with EQT for the next phase of growth. With growing demand for reagents and more scientists relying on these critical products, this is a pivotal moment for the business. EQT’s expertise in scaling distributors will help us reach new customers, offer even better service, and bring exciting new products to market,” said Sune Schmølker, CEO of Europa Biosite.

Kate Swann, Senior Industrial Advisor to EQT, commented: “I am excited to be taking on the role of Chairperson of Europa Biosite and to continue the partnership with EQT. The life sciences sector is vital and fast-moving, and Europa Biosite has a compelling opportunity to grow and contribute to its development. Building on my experience as Chairperson of Beijer Ref, another Swedish specialised distribution business, I look forward to supporting the company’s scaling journey.”

Contact
EQT Press Office, press@eqtpartners.com

Downloads

About EQT
EQT is a purpose-driven global investment organization with EUR 273 billion in total assets under management (EUR 142 billion in fee-generating assets under management) as of 31 March 2025, within two business segments – Private Capital and Real Assets. EQT owns portfolio companies and assets in Europe, Asia Pacific and the Americas and supports them in achieving sustainable growth, operational excellence and market leadership.

More info: www.eqtgroup.com
Follow EQT on LinkedInXYouTube and Instagram

About Europa Biosite
Europa Biosite is a specialist distributor of research reagents, carrying a portfolio of over 10 million SKUs to support thousands of researchers across Europe and North America in reaching their research objectives. The company has 180 employees covering 17 countries; the majority of these are scientifically trained and therefore able to provide expert technical support to customers. Over the past 7 years, the company has completed 7 acquisitions, strengthening its commercial footprint and adding innovative products to the portfolio.

More info: www.europabiosite.com

Categories: News

Tags:

Athora to acquire Pension Insurance Corporation Group

CVC Capital Partners

Pension Insurance Corporation Group Limited (“PICG”), ultimate parent company of Pension Insurance Corporation plc (“PIC”), the specialist insurer of UK defined benefit pension schemes, today announces that Athora Holding Limited (“Athora”) has agreed to acquire PICG for approximately £5.7 billion. Athora is a leading pan-European savings and retirement services group with €76 billion of assets under management and administration, on behalf of 2.8 million policyholders.

The transaction means that for the first time in its 20-year history, PIC will be held by a single strategic owner. PIC will become the UK insurance business of Athora and continue operating under the PIC (and penguin) brand. Athora has existing insurance businesses in the Netherlands, Italy, Belgium and Germany. Athora is backed by permanent capital owners, including a strategic minority investment by Apollo Global Management and Athene Holding Limited, and long-term institutional investors such as a wholly owned subsidiary of the Abu Dhabi Investment Authority (“ADIA”).

The transaction creates a total Group with assets of over €130 billion, backing the pensions of more than three million savers and retirees across Europe. PIC will be 45% of Athora’s total assets under management and administration, and will be the largest and fastest growing business in the Group.

PIC has a portfolio of £50.9 billion backing the pensions of 400,000 people. It has £30 billion invested in the UK. To date it has invested £13.8 billion in UK housing and infrastructure, which help provide the secure, inflation-linked cashflows which match its pension liabilities over future decades. PIC has so far paid more than £16 billion in pensions, with a 99% customer satisfaction rating.

The acquisition reinforces PIC’s strategy of providing very high customer service levels and increases its ability to invest in UK housing and infrastructure as Athora supports PIC through the next phase of its growth. This will allow PIC to provide its best pricing across a larger number of pension risk transfer deals.

PICG’s current shareholders are Reinet Fund S.C.A., F.I.S. (“Reinet”) which holds 49.5% of the issued shares, a wholly owned subsidiary of ADIA, with 18.4% of the issued shares, funds managed by CVC Capital Partners (“CVC”), with 17.4%, and funds managed by HPS Investment Partners with 10.2%, as well as employees and other shareholders, who hold c.4% of the issued shares. The transaction, which is subject to regulatory approval, is expected to close in early 2026.

Tracy Blackwell, CEO of PIC, said: “PIC has had an amazing growth story over the past two decades and is now one of Britain’s preeminent pension businesses. This success has been based on a simple purpose, which is to pay the pensions of our current and future policyholders. Athora’s investment is validation of what we have always believed: that PIC’s reputation, strategy, fortress balance sheet, purpose, and most importantly our people combine to make this a unique business in a huge and growing market.

“With Athora backing us through our next phase of growth as their UK insurance business, we will be able to provide more options to the trustees of defined benefit pension schemes and invest more in UK housing and infrastructure. The pension risk transfer market is vital to the wellbeing of millions of UK pensioners and the allocation of tens of billions of pounds of investment into the UK’s economy. This acquisition and the potential for growth that it represents is the strongest possible recognition of the value and importance of the pension risk transfer market, the sector that PIC helped to create and continues to lead.

“Finally, I want to thank our exiting shareholders who have been absolutely brilliant in getting us to this point. I very much look to the next chapter in PIC’s story.”

Mike Wells, CEO of Athora, said: “We are delighted to have agreed this transaction. We have followed PIC’s progress for several years and been consistently impressed by the very high-quality business the PIC team has built. As our UK subsidiary, PIC will be the largest business within the Athora Group and we intend to invest in the business and its people to support that growth in the UK pension risk transfer market. We have great confidence in the long-term strengths of the UK: its retirement market, regulatory and policy framework, and economic prospects.”

Dillie Malherbe, Director: Reinet Investments Manager, said: “We have been invested in PICG since 2012, and have helped oversee a 900% increase in the size of the business since then, by size of financial investments. What has consistently impressed me about PIC is that, despite that amazing growth trajectory, it has maintained a relentless focus on outcomes for its policyholders. I want to thank Tracy, our fellow shareholders, and everyone at PIC for all their efforts over the past 13 years.”

Hamad Shahwan Aldhaheri, Executive Director of the Private Equities Department at ADIA, said: “As a shareholder in PICG since 2018, our investment supported the growth of the company as it strengthened its position as one of the leading players in the UK pension risk transfer market. Following this transaction, we will maintain exposure to the company via our existing shareholding in Athora, and believe that PIC has strong prospects for the future. We wish the company continued success as part of Athora.”

Quotes

We are pleased to have utilised the longer duration capital of CVC’s Strategic Opportunities platform to partner with the team at PIC over the past eight years.

Peter RutlandManaging Partner at CVC

Peter Rutland, Managing Partner at CVC, said: “We are pleased to have utilised the longer duration capital of CVC’s Strategic Opportunities platform to partner with the team at PIC over the past eight years, during which time the company has scaled substantially and firmly established itself as a leading player in the UK pension insurance market. We wish the company every continued success under Athora’s ownership.”

Categories: News

Tags:

FSN Capital VI to acquire Volue Infrastructure, a leading provider of niche infrastructure software

FSN Capital VI* has signed an agreement to acquire Volue Infrastructure, a Norwegian leader in mission-critical niche infrastructure software. This investment will support Volue Infrastructure’s next phase of growth, further strengthening its position as a trusted software provider to key infrastructure sectors.

Volue Infrastructure’s modular, cutting-edge software tools are at the forefront of infrastructure digitalization. Its comprehensive product suite supports planning, operation and administration for both public and private customers. Backed by FSN Capital VI, the company is well-positioned to execute its growth strategy, leveraging FSN Capital’s expertise in B2B software and internationalization.

Headquartered in Trondheim, Volue Infrastructure is being carved out from Volue, a leader in technologies and services that enable the energy transition. Volue Infrastructure operates mainly under the Gemini brand in two business areas: Water & Community and Heavy Construction. Both markets are poised for significant growth, driven by investment in aging infrastructure, regulatory pressures, accelerating digital adoption and ESG awareness.

Frode Solem, Executive Vice President, Infrastructure at Volue, said: “This is a natural next step for us. As an independent company focused on infrastructure technology, we are well positioned to continue delivering value to our customers while exploring new opportunities for growth. I’m proud of what we’ve built at Volue and excited about what comes next for the team and our solutions as we partner with FSN.”

Eirik H. Wabø, Investment Director at FSN Capital Partners (investment advisor to FSN Capital VI) commentedVolue Infrastructure is an established market leader in providing essential software for the infrastructure sector. We are excited to support their ambitious vision for growth and innovation, building on their strong customer relationships and trusted reputation. We look forward to supporting in accelerating their expansion in Norway and internationally, empowering more communities and industries to benefit from Volue Infrastructure’s outstanding solutions.”

Patrice Jabet, Partner and Technology Sector Lead at FSN Capital Partners, added: “Partnering with Volue Infrastructure to unlock its potential as a standalone business represents an exciting opportunity for FSN Capital VI. We believe the company’s success is rooted in its deep domain expertise and mission-critical solutions, built over decades in close collaboration with customers. FSN Capital VI is well-positioned to support the company’s continued development, drawing on 25 years of experience of the FSN Capital Funds in B2B software, executing carve-outs, and serving infrastructure end-markets.”

The FSN Capital Funds have a strong track record of investing in B2B software, with recent examples including TASKING and Lobster, as well as from partnering with infrastructure-focused businesses such as Saferoad, ViaCon, IMPREG and most recently, UHL Bau.

The parties have agreed not to disclose details of the transaction. The transaction is subject to approval by applicable authorities. Closing is expected later this year.

FSN Capital VI was advised by Wikborg Rein (legal), KPMG (financial, tax and carve-out), EY-Parthenon (commercial and ESG), Code & Co (technology), ABG Sundal Collier (M&A) and Marsh (insurance).

*FSN Capital GP VI Limited, acting for itself and in its capacity as general partner or portfolio manager (as applicable) for and on behalf of each of FSN Capital VI L.P., FSN Capital VI Invest L.P. and FSN Capital VI Lux SCSp.

About Volue Infrastructure
Volue Infrastructure will be divested from Volue, a market leader in technologies and services that power the green transition. Based on 50 years of experience, Volue provides innovative solutions, systems, and insights to industries critical to society. Volue Infrastructure is headquartered in Trondheim, Norway and has more than 100 employees. The company serves two verticals, Water & Communities and Heavy Construction, with a comprehensive software suite providing industry-leading solutions to over 1000 customers.

About FSN Capital
Established in 1999, FSN Capital Partners is a leading Northern European private equity firm and investment advisor to the FSN Capital Funds. FSN Capital Partners has a team of more than 100 across Oslo, Stockholm, Copenhagen, and Munich.

FSN Capital Funds have more than €4 billion under management and make control investments in growth-oriented Northern European companies, to support further growth and to transform companies into more sustainable, competitive, international, and profitable entities.

Our ethos, “We are decent people making a decent return in a decent way”defines our core values. We are committed to being responsible investors and having a positive environmental and social impact across our portfolio while achieving market-leading returns.

Learn more about FSN Capital and our team on our website: www.fsncapital.com

 


 

For more information, please contact the following persons at FSN Capital Partners (investment advisor to the FSN Capital Funds):

Eirik H. Wabø, Investment Director
eirik.wabo@fsncapital.com

Patrice Jabet, Partner
patrice.jabet@fsncapital.com

Morten Welo, Partner & COO/IR
morten.welo@fsncapital.com 

Categories: News

Tags:

Olo Enters into Definitive Agreement to be Acquired by Thoma Bravo

Thomabravo

Olo Shareholders to Receive $10.25 Per Share in Cash, a 65% Premium to Olo’s Unaffected Share Price

Transaction to accelerate Olo’s growth and enhance offerings for restaurant brands worldwide

NEW YORKOlo Inc. (NYSE:OLO) (“Olo” or the “Company”), a leading open SaaS platform for restaurants, today announced that it has entered into a definitive agreement to be acquired by Thoma Bravo, a leading software investment firm, in an all-cash transaction valuing Olo at approximately $2.0 billion in equity value. The transaction is expected to help accelerate Olo’s growth and strengthen its platform and offerings for the over 750 restaurant brands it serves globally. Upon completion of the transaction, Olo will become a privately held company.

Under the terms of the agreement, Olo shareholders will receive $10.25 per share in cash. The per-share purchase price represents a premium of 65% over Olo’s unaffected share price of $6.20 as of April 30, 2025, the last trading day prior to media reports regarding a potential transaction.

Founded in 2005, Olo is a leading restaurant technology provider of digital ordering, payments, and guest engagement solutions that help brands increase orders, streamline operations, and improve the guest experience. Olo processes millions of transactions per day on its open SaaS platform and aggregates transaction data into a single source to help restaurants better understand and serve their guests. Olo serves over 750 restaurant brands and 88,000 locations and has a network of more than 400 integration partners.

“Over the last twenty years, we’ve built Olo into the market leader in digital ordering for restaurants, while also expanding into payments and guest engagement to help restaurant brands aggregate and activate guest data to drive profitable traffic,” said Noah Glass, Olo’s Founder and CEO. “By partnering with Thoma Bravo, we believe we can build on our success to date and accelerate our vision of helping our customers create a world where every restaurant guest feels like a regular.”

“It’s been amazing to watch the growth and evolution of Olo over the years. Noah’s vision and tenacity have created the leader in digital ordering, empowering restaurants to better and more efficiently serve their customers,” said Brandon Gardner, Chair of the Board of Olo. “The company’s strong market position has allowed us to achieve a significant premium through this transaction, and the Board unanimously believes that this is in the best interest of our shareholders.”

“We are thrilled to be joining Noah and the Olo team at this exciting stage of their journey,” said Hudson Smith, a Partner at Thoma Bravo. “The incredible platform and deep customer relationships they’ve built over the last two decades make them an ideal investment for us. We look forward to supporting them as they capitalize on the significant opportunities in the hospitality sector and work to achieve their impressive vision.”

“Noah is a visionary who helped create the digital ordering category for restaurants, and Olo’s platform has earned the trust of many of the world’s most iconic restaurant brands,” said Peter Hernandez, a Senior Vice President at Thoma Bravo. “We see tremendous potential ahead and are incredibly excited to work with Noah and his team on strategic and operational initiatives to help Olo accelerate growth and strengthen their position as an essential partner to restaurants everywhere.”

Transaction Details

The transaction, which was unanimously approved by the Olo Board of Directors, is expected to close by the end of calendar year 2025, subject to customary closing conditions, including approval by Olo shareholders and the receipt of required regulatory approvals. The transaction is not subject to a financing condition.

Upon completion of the transaction, Olo common stock will no longer be listed on any public stock exchange. The Company will continue to operate under the Olo name and brand.

Advisors

Goldman Sachs is serving as the exclusive financial advisor and Goodwin Procter LLP is serving as legal counsel to Olo. Kirkland & Ellis LLP is serving as legal counsel to Thoma Bravo.

About Olo

Olo (NYSE: OLO) is a leading restaurant technology provider with ordering, payment, and guest engagement solutions that help brands increase orders, streamline operations, and improve the guest experience. Each day, Olo processes millions of orders on its open SaaS platform, gathering the right data from each touchpoint into a single source—so restaurants can better understand and better serve every guest on every channel, every time. Over 750 restaurant brands trust Olo and its network of more than 400 integration partners to innovate on behalf of the restaurant community, accelerating technology’s positive impact and creating a world where every restaurant guest feels like a regular. Learn more at olo.com.

About Thoma Bravo

Thoma Bravo is one of the largest software-focused investors in the world, with approximately $184 billion in assets under management as of March 31, 2025. Through its private equity, growth equity and credit strategies, the firm invests in growth-oriented, innovative companies operating in the software and technology sectors. Leveraging Thoma Bravo’s deep sector knowledge and strategic and operational expertise, the firm collaborates with its portfolio companies to implement operating best practices and drive growth initiatives. Over the past 20+ years, the firm has acquired or invested in approximately 535 companies representing approximately $275 billion in enterprise value (including control and non-control investments). The firm has offices in Chicago, Dallas, London, Miami, New York and San Francisco. For more information, visit Thoma Bravo’s website at thomabravo.com.

Forward-Looking Statements

This communication and Olo’s (the “Company”) other filings and press releases may contain forward-looking statements, which include all statements that do not relate solely to historical or current facts, such as statements regarding our expectations, intentions or strategies regarding the future. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “aim,” “potential,” “continue,” “ongoing,” “goal,” “can,” “seek,” “target” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements are based on management’s current beliefs, as well as assumptions made by, and information currently available to, the Company, all of which are subject to change. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected and are subject to a number of known and unknown risks and uncertainties, including: (i) the risk that the proposed merger may not be completed in a timely manner or at all, which may adversely affect the Company’s business and the price of the Company’s common stock; (ii) the failure to satisfy any of the conditions to the consummation of the proposed merger (the “Merger”), including the receipt of certain regulatory approvals; (iii) the failure to obtain stockholder approval; (iv) the occurrence of any fact, event, change, development or circumstance that could give rise to the termination of the merger agreement with Project Hospitality Parent, LLC (“Parent”) and Project Hospitality Merger Sub, Inc. (“Merger Sub”) (the “Merger Agreement”), including in circumstances requiring the Company to pay a termination fee; (v) the effect of the announcement or pendency of the proposed transaction on the Company’s business relationships, operating results and business generally; (vi) risks that the proposed transaction disrupts the Company’s current plans and operations; (vii) the Company’s ability to retain and hire key personnel and maintain relationships with key business partners and customers, and others with whom it does business, in light of the proposed transaction; (viii) risks related to diverting management’s attention from the Company’s ongoing business operations; (ix) unexpected costs, charges or expenses resulting from the proposed Merger; (x) potential litigation relating to the Merger that could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers, including the effects of any outcomes related thereto; (xi) continued availability of capital and financing and rating agency actions; (xii) certain restrictions during the pendency of the Merger that may impact the Company’s ability to pursue certain business opportunities or strategic transactions; (xiii) unpredictability and severity of catastrophic events, including but not limited to acts of terrorism, war or hostilities, as well as management’s response to any of the aforementioned factors; (xiv) the impact of adverse general and industry-specific economic and market conditions; (xv) uncertainty as to timing of completion of the proposed Merger; (xvi) legislative, regulatory and economic developments affecting the Company’s business and (xvii) other risks described in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), such risks and uncertainties described under the headings “Forward-Looking Statements,” “Risk Factors” and other sections of the Company’s Annual Report on Form 10-K filed with the SEC on February 25, 2025, the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 8, 2025, and subsequent filings. No list or discussion of risks or uncertainties should be considered a complete statement of all potential risks and uncertainties. Unlisted or unknown factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, and legal liability to third parties and similar risks, any of which could have a material adverse effect on the completion of the Merger and/or the Company’s consolidated financial condition, results of operations, credit rating or liquidity. The forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to provide revisions or updates to any forward-looking statements, whether as a result of new information, future events or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Additional Information and Where to Find It

In connection with the proposed transaction by and among the Company, a Delaware corporation, Parent, a Delaware limited liability company, and Merger Sub, a Delaware corporation and a wholly-owned subsidiary of Parent, this communication is being made in respect of the pending Merger involving the Company and Parent. The Company will file with the SEC a proxy statement on Schedule 14A relating to its special meeting of stockholders and may file or furnish other documents with the SEC regarding the pending Merger. When completed, a definitive proxy statement will be mailed to the Company’s stockholders. This document is not a substitute for the proxy statement or any other document which the Company may file with the SEC. INVESTORS ARE URGED TO CAREFULLY READ THE PROXY STATEMENT REGARDING THE PENDING MERGER AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS AND DOCUMENTS INCORPORATED BY REFERENCE THEREIN, IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PENDING MERGER AND RELATED MATTERS.

The definitive proxy statement will be filed with the SEC and mailed or otherwise made available to the Company’s stockholders. The Company’s stockholders may obtain free copies of the documents the Company files with the SEC from the SEC’s website at www.sec.gov or through the Investors portion of the Company’s website at investors.olo.com under the link “Financials” and then under the link “SEC Filings” or by contacting the Company’s Investor Relations by e-mail at InvestorRelations@olo.com.

Participants in the Solicitation

The Company and certain of its directors and executive officers may be deemed to be participants in the solicitation of proxies from the Company’s stockholders in connection with the pending Merger. Information regarding the Company’s directors and executive officers, including a description of their direct interests, by security holdings or otherwise, is contained in the Company’s 2025 annual proxy statement for its 2025 annual meeting of stockholders, which was filed with the SEC on April 24, 2025. Other information regarding the participants in the proxy solicitation and a description of their interests will be contained in the proxy statement for the Company’s special meeting of stockholders and other relevant materials to be filed with the SEC in respect of the proposed Merger when they become available. These documents can be obtained free of charge from the sources indicated above.

Read the release on Business Wire here.

Categories: News

Tags:

Solifi acquires lease and loan management technology company Leasepath

Thomabravo

The acquisition will complement Solifi’s product portfolio by adding a solution aimed at the small-to-mid-market secured finance segment.

Solifi, a global SaaS leader for secured finance, announced the acquisition of Leasepath, a leading middle-market provider of global equipment finance loan and lease management technology.

This strategic acquisition accelerates Solifi’s expansion and solution portfolio into the mid-market sector and will facilitate the sharing of know-how, in-depth expertise, and resources between Solifi and Leasepath with the objectives of accelerating growth and reinforcing market leadership status.

“Leasepath is an exciting addition to Solifi’s portfolio of proven secured finance solutions”, commented Dan Corazzi, Solifi CEO. “Not only does this acquisition enable Leasepath to diversify its financial service offerings and target additional markets, including EMEA and APAC, but it also amplifies Solifi’s growth opportunities in the mid-market sector”.

Leasepath will continue to be led by Jeff Bilbrey, who added: “This acquisition represents a key milestone in our company’s journey, enabling us to continue to serve our existing customers and focus on our future expansion objectives”.

Solifi and Leasepath will offer their existing solutions, products, and services to their customer base. Both companies will retain their current operations from their headquarters and regional offices.

About Leasepath

A growing SaaS B2B company serving the commercial asset finance industry, Leasepath is the only provider of global lease and loan management solutions in the equipment finance space built on the cloud-first technology of Microsoft Dynamics. For the past 30 years, the company has grown its customer base in North America, UK and Australia through the delivery of reliable equipment finance loan and lease management solutions. For more information, visit www.leasepath.com.

Read the release on the Solifi website here.

Categories: News

Tags: